July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Association of APOE with POAG suggests a protective effect for APOE4
Author Affiliations & Notes
  • Sophia M Letcher
    Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
  • Milica Margeta
    Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
  • Robert P. Igo
    Case Western Reserve University School of Medicine, Ohio, United States
  • Jessica Cooke Bailey
    Case Western Reserve University School of Medicine, Ohio, United States
  • Jonathan L Haines
    Case Western Reserve University School of Medicine, Ohio, United States
  • Oleg Butovsky
    Brigham and Women's Hospital, Massachusetts, United States
  • Janey L Wiggs
    Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Sophia Letcher, None; Milica Margeta, None; Robert Igo, None; Jessica Cooke Bailey, None; Jonathan Haines, None; Oleg Butovsky, None; Janey Wiggs, None
  • Footnotes
    Support  NIH/NEI R01 EY022305, NIH/NEI K12 EY016335
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 1627. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sophia M Letcher, Milica Margeta, Robert P. Igo, Jessica Cooke Bailey, Jonathan L Haines, Oleg Butovsky, Janey L Wiggs; Association of APOE with POAG suggests a protective effect for APOE4. Invest. Ophthalmol. Vis. Sci. 2019;60(9):1627.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Primary open angle glaucoma (POAG) is a genetically and clinically heterogeneous disease characterized by retinal ganglion cell apoptosis. In neurodegenerative diseases of the brain, including Alzheimer’s disease (AD), neuronal death leads to induction of a neurodegeneration-associated transcriptional phenotype in microglia, the resident macrophages of the brain. Here we sought to identify genetic associations between POAG and APOE and TREM2, two genes that are known to be critically involved in regulation of microglial neurodegenerative phenotype and are established risk factors for AD.

Methods : APOE genotypes (alleles 2, 3, and 4) were identified using imputed data from the NEIGHBOR consortium (2606 cases and 2606 controls). The dataset was analyzed for association with POAG and the high-tension (HTG) and normal-tension (NTG) subgroups using logistic regression controlling for age, gender and population-specific eigenvectors and covariates. A likelihood ratio test was done to compare the logistic regression models. TREM2 data was extracted from exome-wide genotypes using the human exome bead array.

Results : Significant association was observed for the APOE4 allele in POAG overall (P= 0.0022, OR 0.834) and in both the HTG and NTG subgroups (P=0.0052, OR 0.801) and (P= 0.0014, OR 0.712) respectively. Significant association was not observed for either the APOE2 or APOE3 alleles. Interestingly, the APOE4 allele effect is protective in POAG and in HTG and NTG, with greatest effect in NTG. The likelihood ratio test (LRT) confirmed these findings and demonstrated the largest effect with NTG (P= 0.0041). A rare TREM2 variant (A105V) was found only in POAG cases (3 of 2846 cases, allele frequency 0.00053) and in none of 2606 controls. Compared with population data from ExAC the distribution in cases was significant (P=0.02). Other TREM2 rare variants associated with AD, including R62H, were not significantly associated with POAG (P > 0.24).

Conclusions : We have found that the APOE4 allele is protective in POAG, especially NTG, in this relatively large dataset. Interestingly, the risk effect is similar to what has been observed for age-related macular degeneration but opposite of that for AD, suggesting a mechanistic difference between neurodegenerative diseases of the eye and the brain. Rare TREM2 variants may also contribute to POAG risk, however these appear to be different variants when compared with AD.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×